|
1
|
International Agency for Research on
Cancer, : GLOBOCAN 2008: Cancer Incidence, Mortality and Prevalence
Worldwide. https://www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gu F: Epidemiological survey of benign
prostatic hyperplasia and prostatic cancer in China. Chin Med J
(Engl). 113:299–302. 2000.PubMed/NCBI
|
|
4
|
Lichrenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki
K: Environmental and heritable factors in the causation of cancer -
analyses of cohorts of twins from Sweden, Denmark, and Finland. N
Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gu F: Changing constituents of
genitourinary cancer in recent 50 years in Beijing. Chin Med J
(Engl). 116:1391–1393. 2003.PubMed/NCBI
|
|
6
|
Qi JL, Wang LJ, Zhou MG, Liu YN, Liu JM,
Liu SW, Zeng XY and Yin P: Disease burden of prostate cancer among
men in China, from 1990 to 2013. Zhonghua Liu Xing Bing Xue Za Zhi.
37:778–782. 2016.(In Chinese). PubMed/NCBI
|
|
7
|
Bosco A and Golsteyn RM: Emerging
anti-mitotic activities and other bioactivities of sesquiterpene
compounds upon human cells. Molecules. 22:E4592017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Song Y, Che J, Liu X, Ning Y, Shan
C, Hou Y, Liu Y, Miao X and Cheng Y: Validation of a sensitive gas
chromatographic-mass spectrometric method for the simultaneous
determination of beta-elemene and beta-elemenal in human plasma. J
Chromatogr B Analyt Technol Biomed Life Sci. 877:408–414. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmittgen TD, Zakrajsek BA, Mills AG,
Gorn V, Singer MJ and Reed MW: Quantitative reverse
transcription-polymerase chain reaction to study mRNA decay:
Comparison of endpoint and real-time methods. Anal Biochem.
285:194–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Montgomery BT, Young CY, Bilhartz DL,
Andrews PE, Prescott JL, Thompson NF and Tindall DJ: Hormonal
regulation of prostate-specific antigen (PSA) glycoprotein in the
human prostatic adenocarcinoma cell line, LNCaP. Prostate.
21:63–73. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Young CYF, Montgomery BT, Andrews PE, Qui
SD, Bilhartz DL and Tindall DJ: Hormonal regulation of
prostate-specific antigen messenger RNA in human prostatic
adenocarcinoma cell line LNCaP. Cancer Res. 51:3748–3752.
1991.PubMed/NCBI
|
|
12
|
Chen CD, Welsbie DS, Tran C, Baek SH, Chen
R, Vessella R, Rosenfeld MG and Sawyers CL: Molecular determinants
of resistance to antiandrogen therapy. Nat Med. 10:33–39. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taplin ME and Balk SP: Androgen receptor:
A key molecule in the progression of prostate cancer to hormone
independence. J Cell Biochem. 91:483–490. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weiss-Messer E, Merom O, Adi A, Karry R,
Bidosee M, Ber R, Kaploun A, Stein A and Barkey RJ: Growth hormone
(GH) receptors in prostate cancer: Gene expression in human tissues
and cell lines and characterization, GH signaling and androgen
receptor regulation in LNCaP cells. Mol Cell Endocrinol.
220:109–123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv T, Tian BQ, Zheng XM and Li SW: Changes
of androgen receptor expression in hormonal dependent prostatic
cancer and hormonal independent prostatic cancer. Wuhan Daxue
Xuebao Yixue Ban. 28:181–184. 2007.(In Chinese).
|
|
16
|
Cory S, Huang DCS and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Packham G and Cleveland JL: c-Myc and
apoptosis. Biochim Biophys Acta. 1242:11–28. 1995.PubMed/NCBI
|
|
18
|
Brady HJ and Gil-Gómez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: Role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung
JH, Yun SM, Han I, Lee SG, Kim DK, Kang M, et al: Janus activated
kinase 2/signal transducer and activator of transcription 3 pathway
mediates icariside II-induced apoptosis in U266 multiple myeloma
cells. Eur J Pharmacol. 654:10–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Myong NH: Tissue microarray analysis of
Fas and FasL expressions in human non-small cell lung carcinomas;
with reference to the p53 and bcl-2 overexpressions. J Korean Med
Sci. 20:770–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang JS, Hsu YL, Kuo PL, Chiang LC and
Lin CC: Upregulation of Fas/Fas ligand-mediated apoptosis by
gossypol in an immortalized human alveolar lung cancer cell line.
Clin Exp Pharmacol Physiol. 31:716–722. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xi S, Dyer KF, Kimak M, Zhang Q, Gooding
WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, et al:
Decreased STAT1 expression by promoter methylation in squamous cell
carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B, Lai Y, Li Y, Shu N, Wang Z, Wang
Y, Li Y and Chen Z: Antineoplastic activity of isoliquiritigenin, a
chalcone compound, in androgen-independent human prostate cancer
cells linked to G2/M cell cycle arrest and cell apoptosis. Eur J
Pharmacol. 821:57–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Messaris E, Kekis P, Memos N, Chatzigianni
E, Menenakos E, Leandros E and Konstadoulakis MM: Sepsis:
Prognostic role of apoptosis regulators in gastrointestinal cells.
World J Surg. 31:787–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
